{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:23Z","timestamp":1786980143419,"version":"build-2736575974"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ1007"],"award-info":[{"award-number":["2024JJ1007"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ9436"],"award-info":[{"award-number":["2024JJ9436"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018597","name":"Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education","doi-asserted-by":"publisher","award":["2022FTKFJJ06"],"award-info":[{"award-number":["2022FTKFJJ06"]}],"id":[{"id":"10.13039\/501100018597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251170"],"award-info":[{"award-number":["CX20251170"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251150"],"award-info":[{"award-number":["CX20251150"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251177"],"award-info":[{"award-number":["CX20251177"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00415-026-13928-5","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:01:38Z","timestamp":1782324098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioenergetic failure in diabetic peripheral neuropathy: from glucotoxicity to multidimensional metabolic imbalance"],"prefix":"10.1007","volume":"273","author":[{"given":"Wang","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-3448","authenticated-orcid":false,"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"13928_CR1","doi-asserted-by":"publisher","DOI":"10.2337\/db2022-01","author":"R Pop-Busui","year":"2022","unstructured":"Pop-Busui R, Ang L, Boulton AJM et al (2022) Diagnosis and treatment of painful diabetic peripheral neuropathy. American Diabetes Association. https:\/\/doi.org\/10.2337\/db2022-01","journal-title":"American Diabetes Association"},{"key":"13928_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043554","volume":"24","author":"R Galiero","year":"2023","unstructured":"Galiero R, Caturano A, Vetrano E et al (2023) Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options. Int J Mol Sci 24:3554. https:\/\/doi.org\/10.3390\/ijms24043554","journal-title":"Int J Mol Sci"},{"key":"13928_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.534372","author":"Y Lu","year":"2020","unstructured":"Lu Y, Xing P, Cai X et al (2020) Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: estimates of the INTERPRET-DD study. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2020.534372","journal-title":"Front Public Health"},{"key":"13928_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00617","author":"Q Pan","year":"2018","unstructured":"Pan Q, Li Q, Deng W et al (2018) Prevalence of and risk factors for peripheral neuropathy in chinese patients with diabetes: a multicenter cross-sectional study. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2018.00617","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13928_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-002040","volume":"9","author":"V Kirthi","year":"2021","unstructured":"Kirthi V, Perumbalath A, Brown E et al (2021) Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res Care 9:e002040. https:\/\/doi.org\/10.1136\/bmjdrc-2020-002040","journal-title":"BMJ Open Diabetes Res Care"},{"key":"13928_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020165","author":"J Burgess","year":"2021","unstructured":"Burgess J, Frank B, Marshall A et al (2021) Early detection of diabetic peripheral neuropathy: a focus on small nerve fibres. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics11020165","journal-title":"Diagnostics (Basel)"},{"key":"13928_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265372","author":"J Zhu","year":"2024","unstructured":"Zhu J, Hu Z, Luo Y et al (2024) Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2023.1265372","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"13928_CR8","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","volume":"160","author":"A DiAntonio","year":"2019","unstructured":"DiAntonio A (2019) Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy. Pain 160(Suppl 1):S17\u2013S22. https:\/\/doi.org\/10.1097\/j.pain.0000000000001528","journal-title":"Pain"},{"key":"13928_CR9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","volume":"21","author":"MA Elafros","year":"2022","unstructured":"Elafros MA, Andersen H, Bennett DL et al (2022) Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol 21:922\u2013936. https:\/\/doi.org\/10.1016\/S1474-4422(22)00188-0","journal-title":"Lancet Neurol"},{"key":"13928_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2022.100360","author":"JA Barnes-V\u00e9lez","year":"2023","unstructured":"Barnes-V\u00e9lez JA, Aksoy Yasar FB, Hu J (2023) Myelin lipid metabolism and its role in myelination and myelin maintenance. Innovation. https:\/\/doi.org\/10.1016\/j.xinn.2022.100360","journal-title":"Innovation"},{"key":"13928_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01080-z","author":"SC Previtali","year":"2021","unstructured":"Previtali SC (2021) Peripheral nerve development and the pathogenesis of peripheral neuropathy: the sorting point. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-021-01080-z","journal-title":"Neurotherapeutics"},{"key":"13928_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1073858415572361","author":"ML Feltri","year":"2016","unstructured":"Feltri ML, Poitelon Y, Previtali SC (2016) How Schwann cells sort axons: new concepts. Neuroscientist. https:\/\/doi.org\/10.1177\/1073858415572361","journal-title":"Neuroscientist"},{"key":"13928_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910785","author":"NHA Razak","year":"2024","unstructured":"Razak NHA, Idris J, Hassan NH et al (2024) Unveiling the role of schwann cell plasticity in the pathogenesis of diabetic peripheral neuropathy. Intern J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251910785","journal-title":"Intern J Mol Sci"},{"key":"13928_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fncel.2019.00033","volume":"13","author":"KR Jessen","year":"2019","unstructured":"Jessen KR, Mirsky R (2019) The success and failure of the Schwann cell response to nerve injury. Front Cell Neurosci 13:33. https:\/\/doi.org\/10.3389\/fncel.2019.00033","journal-title":"Front Cell Neurosci"},{"key":"13928_CR15","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/glia.23643","volume":"67","author":"S Stierli","year":"2019","unstructured":"Stierli S, Imperatore V, Lloyd AC (2019) Schwann cell plasticity-roles in tissue homeostasis, regeneration, and disease. Glia 67:2203\u20132215. https:\/\/doi.org\/10.1002\/glia.23643","journal-title":"Glia"},{"key":"13928_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1083\/jcb.48.2.348","volume":"48","author":"HdeF Webster","year":"1971","unstructured":"Webster HdeF (1971) The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J Cell Biol 48:348\u2013367. https:\/\/doi.org\/10.1083\/jcb.48.2.348","journal-title":"J Cell Biol"},{"key":"13928_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040812","author":"Y Poitelon","year":"2020","unstructured":"Poitelon Y, Kopec AM, Belin S (2020) Myelin fat facts: an overview of lipids and fatty acid metabolism. Cells. https:\/\/doi.org\/10.3390\/cells9040812","journal-title":"Cells"},{"key":"13928_CR18","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1074\/jbc.M114.631291","volume":"290","author":"W Hao","year":"2015","unstructured":"Hao W, Tashiro S, Hasegawa T et al (2015) Hyperglycemia promotes Schwann cell de-differentiation and de-myelination via sorbitol accumulation and Igf1 protein down-regulation. J Biol Chem 290:17106\u201317115. https:\/\/doi.org\/10.1074\/jbc.M114.631291","journal-title":"J Biol Chem"},{"key":"13928_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199724","author":"NHA Razak","year":"2025","unstructured":"Razak NHA, Vijakumaran U, Idris IM, Idris J et al (2025) Hyperglycemia modulates mTOR signaling and myelin protein expression in Schwann cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26199724","journal-title":"Int J Mol Sci"},{"key":"13928_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jnc.15877","volume":"166","author":"SA Eid","year":"2023","unstructured":"Eid SA, Noureldein M, Kim B et al (2023) Single-cell RNA-seq uncovers novel metabolic functions of Schwann cells beyond myelination. J Neurochem 166:367\u2013388. https:\/\/doi.org\/10.1111\/jnc.15877","journal-title":"J Neurochem"},{"key":"13928_CR21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.4103\/1673-5374.327334","volume":"17","author":"CL Walker","year":"2022","unstructured":"Walker CL (2022) Progress in perisynaptic Schwann cell and neuromuscular junction research. Neural Regen Res 17:1273. https:\/\/doi.org\/10.4103\/1673-5374.327334","journal-title":"Neural Regen Res"},{"key":"13928_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092131","author":"S Bol\u00edvar","year":"2020","unstructured":"Bol\u00edvar S, Navarro X, Udina E (2020) Schwann cell role in selectivity of nerve regeneration. Cells. https:\/\/doi.org\/10.3390\/cells9092131","journal-title":"Cells"},{"key":"13928_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.neuron.2012.06.021","volume":"75","author":"PJ Arthur-Farraj","year":"2012","unstructured":"Arthur-Farraj PJ, Latouche M, Wilton DK et al (2012) c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75:633\u2013647. https:\/\/doi.org\/10.1016\/j.neuron.2012.06.021","journal-title":"Neuron"},{"key":"13928_CR24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46501","volume":"15","author":"AH Siddiqui","year":"2023","unstructured":"Siddiqui AH, Tauheed N, Ashraf H, Ahmad J (2023) Association of sensory nerve action potential amplitude and velocity with type 2 diabetic peripheral neuropathy. Cureus 15:e46501. https:\/\/doi.org\/10.7759\/cureus.46501","journal-title":"Cureus"},{"key":"13928_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.15537\/smj.2016.3.13625","volume":"37","author":"V Toopchizadeh","year":"2016","unstructured":"Toopchizadeh V, Shiva S, Khiabani N-Y, Ghergherechi R (2016) Electrophysiologic pattern and prevalence of subclinical peripheral neuropathy in children and adolescents with type I diabetes mellitus in Iran. Saudi Med J 37:299\u2013303. https:\/\/doi.org\/10.15537\/smj.2016.3.13625","journal-title":"Saudi Med J"},{"issue":"4","key":"13928_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/106.4.791","volume":"106","author":"G Said","year":"1983","unstructured":"Said G, Slama G, Selva J (1983) Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 106(4):791\u2013807. https:\/\/doi.org\/10.1093\/brain\/106.4.791","journal-title":"Brain"},{"issue":"2","key":"13928_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/brain\/114.2.867","volume":"114","author":"JG Llewelyn","year":"1991","unstructured":"Llewelyn JG, Gilbey SG, Thomas PK et al (1991) Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114(2):867\u2013892. https:\/\/doi.org\/10.1093\/brain\/114.2.867","journal-title":"Brain"},{"key":"13928_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/jnnp.40.11.1072","volume":"40","author":"F Behse","year":"1977","unstructured":"Behse F, Buchthal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40:1072\u20131082. https:\/\/doi.org\/10.1136\/jnnp.40.11.1072","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13928_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-008-0872-0","volume":"255","author":"S L\u00f8seth","year":"2008","unstructured":"L\u00f8seth S, St\u00e5lberg E, Jorde R, Mellgren SI (2008) Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol 255:1197\u20131202. https:\/\/doi.org\/10.1007\/s00415-008-0872-0","journal-title":"J Neurol"},{"key":"13928_CR30","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.2337\/db07-0285","volume":"56","author":"C Quattrini","year":"2007","unstructured":"Quattrini C, Tavakoli M, Jeziorska M et al (2007) Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56:2148\u20132154. https:\/\/doi.org\/10.2337\/db07-0285","journal-title":"Diabetes"},{"key":"13928_CR31","unstructured":"Djemli-Shipkolye A, Coste T, Raccah D, et al (2001) Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters. Cell Mol Biol (Noisy-le-grand) 47:297\u2013304"},{"key":"13928_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/brain\/awh476","volume":"128","author":"AV Krishnan","year":"2005","unstructured":"Krishnan AV, Kiernan MC (2005) Altered nerve excitability properties in established diabetic neuropathy. Brain 128:1178\u20131187. https:\/\/doi.org\/10.1093\/brain\/awh476","journal-title":"Brain"},{"key":"13928_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fncel.2019.00373","volume":"13","author":"A Mandal","year":"2019","unstructured":"Mandal A, Drerup CM (2019) Axonal transport and mitochondrial function in neurons. Front Cell Neurosci 13:373. https:\/\/doi.org\/10.3389\/fncel.2019.00373","journal-title":"Front Cell Neurosci"},{"key":"13928_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps S, Julien J-P (2013) Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci 14:161\u2013176. https:\/\/doi.org\/10.1038\/nrn3380","journal-title":"Nat Rev Neurosci"},{"key":"13928_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137286","author":"JP Palavicini","year":"2020","unstructured":"Palavicini JP, Chen J, Wang C et al (2020) Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.137286","journal-title":"JCI Insight"},{"key":"13928_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000300","volume":"8","author":"J Gilley","year":"2010","unstructured":"Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8:e1000300. https:\/\/doi.org\/10.1371\/journal.pbio.1000300","journal-title":"PLoS Biol"},{"key":"13928_CR37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-051424-045840","author":"FI Hinz","year":"2026","unstructured":"Hinz FI, Hoogenraad CC (2026) DLK, NMNAT2, and SARM1: judge, jury, and executioner in axon degeneration. Annu Rev Biochem. https:\/\/doi.org\/10.1146\/annurev-biochem-051424-045840","journal-title":"Annu Rev Biochem"},{"key":"13928_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2517110123","volume":"123","author":"C Chen","year":"2026","unstructured":"Chen C, Zhu L, Li W et al (2026) Hyperglycemia promotes SIRT3-mediated deacetylation of SARM1 to exacerbate diabetic peripheral neuropathy in mice. Proc Natl Acad Sci U S A 123:e2517110123. https:\/\/doi.org\/10.1073\/pnas.2517110123","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13928_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","volume":"109","author":"MD Figley","year":"2021","unstructured":"Figley MD, Gu W, Nanson JD et al (2021) SARM1 is a metabolic sensor activated by an increased NMN\/NAD+ ratio to trigger axon degeneration. Neuron 109:1118-1136.e11. https:\/\/doi.org\/10.1016\/j.neuron.2021.02.009","journal-title":"Neuron"},{"key":"13928_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.589582","volume":"14","author":"MK Jha","year":"2020","unstructured":"Jha MK, Morrison BM (2020) Lactate transporters mediate glia-neuron metabolic crosstalk in homeostasis and disease. Front Cell Neurosci 14:589582. https:\/\/doi.org\/10.3389\/fncel.2020.589582","journal-title":"Front Cell Neurosci"},{"key":"13928_CR41","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/glia.70071","volume":"73","author":"R Follis","year":"2025","unstructured":"Follis R, Prabhu VV, Carter BD (2025) The influence of Schwann cell metabolism and dysfunction on axon maintenance. Glia 73:2338\u20132352. https:\/\/doi.org\/10.1002\/glia.70071","journal-title":"Glia"},{"key":"13928_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","volume":"23","author":"B Kim","year":"2012","unstructured":"Kim B, Feldman EL (2012) Insulin resistance in the nervous system. Trends Endocrinol Metab 23:133\u2013141. https:\/\/doi.org\/10.1016\/j.tem.2011.12.004","journal-title":"Trends Endocrinol Metab"},{"key":"13928_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/212571","volume":"2011","author":"CW Grote","year":"2011","unstructured":"Grote CW, Morris JK, Ryals JM et al (2011) Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy. Exp Diabetes Res 2011:212571. https:\/\/doi.org\/10.1155\/2011\/212571","journal-title":"Exp Diabetes Res"},{"key":"13928_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/glia.23755","volume":"68","author":"AR Hackett","year":"2020","unstructured":"Hackett AR, Strickland A, Milbrandt J (2020) Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy. Glia 68:963\u2013978. https:\/\/doi.org\/10.1002\/glia.23755","journal-title":"Glia"},{"key":"13928_CR45","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.048909","author":"SE Elzinga","year":"2021","unstructured":"Elzinga SE, Savelieff MG, O\u2019Brien PD et al (2021) Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.048909","journal-title":"Dis Model Mech"},{"key":"13928_CR46","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/brain\/awr228","volume":"134","author":"J Hur","year":"2011","unstructured":"Hur J, Sullivan KA, Pande M et al (2011) The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134:3222\u20133235. https:\/\/doi.org\/10.1093\/brain\/awr228","journal-title":"Brain"},{"key":"13928_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2337\/db10-1541","volume":"60","author":"M Pande","year":"2011","unstructured":"Pande M, Hur J, Hong Y et al (2011) Transcriptional profiling of diabetic neuropathy in the BKS db\/db mouse. Diabetes 60:1981\u20131989. https:\/\/doi.org\/10.2337\/db10-1541","journal-title":"Diabetes"},{"key":"13928_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101408","volume":"55","author":"M Leal-Juli\u00e0","year":"2021","unstructured":"Leal-Juli\u00e0 M, Vilches JJ, Onieva A et al (2021) Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice. Mol Metab 55:101408. https:\/\/doi.org\/10.1016\/j.molmet.2021.101408","journal-title":"Mol Metab"},{"key":"13928_CR49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00109-019-01781-1","volume":"97","author":"DR Rojas","year":"2019","unstructured":"Rojas DR, Kuner R, Agarwal N (2019) Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. J Mol Med (Berl) 97:845\u2013854. https:\/\/doi.org\/10.1007\/s00109-019-01781-1","journal-title":"J Mol Med (Berl)"},{"key":"13928_CR50","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.2337\/dc18-0392","volume":"41","author":"ST Andersen","year":"2018","unstructured":"Andersen ST, Witte DR, Andersen H et al (2018) Risk-factor trajectories preceding diabetic polyneuropathy: ADDITION-Denmark. Diabetes Care 41:1955\u20131962. https:\/\/doi.org\/10.2337\/dc18-0392","journal-title":"Diabetes Care"},{"key":"13928_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc16-0081","volume":"39","author":"BC Callaghan","year":"2016","unstructured":"Callaghan BC, Xia R, Banerjee M et al (2016) Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care 39:801\u2013807. https:\/\/doi.org\/10.2337\/dc16-0081","journal-title":"Diabetes Care"},{"key":"13928_CR52","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/dc19-2277","volume":"43","author":"DH Christensen","year":"2020","unstructured":"Christensen DH, Knudsen ST, Gylfadottir SS et al (2020) Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: a nationwide study of 5249 patients in the Danish centre for strategic research in type 2 diabetes (DD2) cohort. Diabetes Care 43:1266\u20131275. https:\/\/doi.org\/10.2337\/dc19-2277","journal-title":"Diabetes Care"},{"key":"13928_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/dc07-1796","volume":"31","author":"D Ziegler","year":"2008","unstructured":"Ziegler D, Rathmann W, Dickhaus T et al (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464\u2013469. https:\/\/doi.org\/10.2337\/dc07-1796","journal-title":"Diabetes Care"},{"key":"13928_CR54","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2337\/dc06-0224","volume":"29","author":"AG Smith","year":"2006","unstructured":"Smith AG, Russell J, Feldman EL et al (2006) Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29:1294\u20131299. https:\/\/doi.org\/10.2337\/dc06-0224","journal-title":"Diabetes Care"},{"key":"13928_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jpha.2023.09.007","volume":"14","author":"B Zhao","year":"2024","unstructured":"Zhao B, Zhang Q, He Y et al (2024) Targeted metabolomics reveals the aberrant energy status in diabetic peripheral neuropathy and the neuroprotective mechanism of traditional Chinese medicine JinMaiTong. J Pharm Anal 14:225\u2013243. https:\/\/doi.org\/10.1016\/j.jpha.2023.09.007","journal-title":"J Pharm Anal"},{"key":"13928_CR56","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/s0026-0495(96)90174-2","volume":"45","author":"P Magnani","year":"1996","unstructured":"Magnani P, Cherian PV, Gould GW et al (1996) Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3. Metabolism 45:1466\u20131473. https:\/\/doi.org\/10.1016\/s0026-0495(96)90174-2","journal-title":"Metabolism"},{"key":"13928_CR57","first-page":"204","volume":"25","author":"OS Sotnikov","year":"1966","unstructured":"Sotnikov OS (1966) Structure of Schmidt-Lantermann incisures. Fed Proc Transl Suppl 25:204\u2013210","journal-title":"Fed Proc Transl Suppl"},{"key":"13928_CR58","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1523\/JNEUROSCI.3534-14.2015","volume":"35","author":"E Dom\u00e8nech-Est\u00e9vez","year":"2015","unstructured":"Dom\u00e8nech-Est\u00e9vez E, Baloui H, Repond C et al (2015) Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination. J Neurosci 35:4151\u20134156. https:\/\/doi.org\/10.1523\/JNEUROSCI.3534-14.2015","journal-title":"J Neurosci"},{"key":"13928_CR59","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s13311-021-01150-2","volume":"18","author":"A Rawat","year":"2021","unstructured":"Rawat A, Morrison BM (2021) Metabolic transporters in the peripheral nerve-what, where, and why? Neurotherapeutics 18:2185\u20132199. https:\/\/doi.org\/10.1007\/s13311-021-01150-2","journal-title":"Neurotherapeutics"},{"key":"13928_CR60","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1038\/s41598-021-82417-8","volume":"11","author":"E Szab\u00f3","year":"2021","unstructured":"Szab\u00f3 E, Kulin A, Kor\u00e1nyi L et al (2021) Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients. Sci Rep 11:2765. https:\/\/doi.org\/10.1038\/s41598-021-82417-8","journal-title":"Sci Rep"},{"key":"13928_CR61","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s13105-013-0263-6","volume":"69","author":"R Nikooie","year":"2013","unstructured":"Nikooie R, Rajabi H, Gharakhanlu R et al (2013) Exercise-induced changes of MCT1 in cardiac and skeletal muscles of diabetic rats induced by high-fat diet and STZ. J Physiol Biochem 69:865\u2013877. https:\/\/doi.org\/10.1007\/s13105-013-0263-6","journal-title":"J Physiol Biochem"},{"key":"13928_CR62","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4103\/1673-5374.380872","volume":"19","author":"Y Lv","year":"2024","unstructured":"Lv Y, Yao X, Li X et al (2024) Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy. Neural Regen Res 19:598\u2013605. https:\/\/doi.org\/10.4103\/1673-5374.380872","journal-title":"Neural Regen Res"},{"key":"13928_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134762","volume":"720","author":"F Li","year":"2020","unstructured":"Li F, Du W, Wang H et al (2020) Activation of AMPK pathway compromises Rab11 downregulation-mediated inhibition of Schwann cell proliferation in a Glut1 and Glut3-dependent manner. Neurosci Lett 720:134762. https:\/\/doi.org\/10.1016\/j.neulet.2020.134762","journal-title":"Neurosci Lett"},{"key":"13928_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113415","volume":"333","author":"MK Jha","year":"2020","unstructured":"Jha MK, Ament XH, Yang F et al (2020) Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy. Exp Neurol 333:113415. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113415","journal-title":"Exp Neurol"},{"key":"13928_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/glia.23889","volume":"69","author":"F Bou\u00e7anova","year":"2021","unstructured":"Bou\u00e7anova F, Pollmeier G, Sandor K et al (2021) Disrupted function of lactate transporter MCT1, but not MCT4, in Schwann cells affects the maintenance of motor end-plate innervation. Glia 69:124\u2013136. https:\/\/doi.org\/10.1002\/glia.23889","journal-title":"Glia"},{"key":"13928_CR66","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/j.pain.0000000000001922","volume":"161","author":"NA Calcutt","year":"2020","unstructured":"Calcutt NA (2020) Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? Pain 161:S65\u2013S86. https:\/\/doi.org\/10.1097\/j.pain.0000000000001922","journal-title":"Pain"},{"key":"13928_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.dsx.2018.09.009","volume":"13","author":"A Rawat","year":"2019","unstructured":"Rawat A, Misra G, Saxena M et al (2019) 1H NMR based serum metabolic profiling reveals differentiating biomarkers in patients with diabetes and diabetes-related complication. Diabetes Metab Syndr 13:290\u2013298. https:\/\/doi.org\/10.1016\/j.dsx.2018.09.009","journal-title":"Diabetes Metab Syndr"},{"key":"13928_CR68","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.3390\/ijms26104666","volume":"26","author":"H Yako","year":"2025","unstructured":"Yako H, Suzuki M, Takaku S et al (2025) Pyruvate administration restores impaired nociception by enhancing neurite outgrowth in streptozotocin-induced diabetic mice. Int J Mol Sci 26:4666. https:\/\/doi.org\/10.3390\/ijms26104666","journal-title":"Int J Mol Sci"},{"key":"13928_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13594-z","author":"S Jiang","year":"2026","unstructured":"Jiang S, Zhang L, Zhao L, Lv Y, Cheng S, Liu C, Xu S, Zhang B (2026) Immunological mechanisms and therapeutic advances in diabetic neuropathy. J Neurol. https:\/\/doi.org\/10.1007\/s00415-025-13594-z","journal-title":"J Neurol"},{"key":"13928_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414547","volume":"12","author":"W Li","year":"2025","unstructured":"Li W, Yang T, Wang N et al (2025) Maladaptive peripheral ketogenesis in Schwann cells mediated by CB1R contributes to diabetic neuropathy. Adv Sci (Weinh) 12:e2414547. https:\/\/doi.org\/10.1002\/advs.202414547","journal-title":"Adv Sci (Weinh)"},{"key":"13928_CR71","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4103\/NRR.NRR-D-24-00262","volume":"20","author":"O Kann","year":"2025","unstructured":"Kann O, S\u00f6der L, Khodaie B (2025) Lactate is a potentially harmful substitute for brain glucose fuel: consequences for metabolic restoration of neurotransmission. Neural Regen Res 20:1403. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00262","journal-title":"Neural Regen Res"},{"key":"13928_CR72","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12967-025-06341-5","volume":"23","author":"F Xiang","year":"2025","unstructured":"Xiang F, Zhang Z, Xie J et al (2025) Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation. J Transl Med 23:324. https:\/\/doi.org\/10.1186\/s12967-025-06341-5","journal-title":"J Transl Med"},{"key":"13928_CR73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling U, Supplie LM, Mahad D et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517\u2013521. https:\/\/doi.org\/10.1038\/nature11007","journal-title":"Nature"},{"key":"13928_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272097","volume":"17","author":"M Deck","year":"2022","unstructured":"Deck M, Van Hameren G, Campbell G et al (2022) Physiology of PNS axons relies on glycolytic metabolism in myelinating Schwann cells. PLoS ONE 17:e0272097. https:\/\/doi.org\/10.1371\/journal.pone.0272097","journal-title":"PLoS ONE"},{"key":"13928_CR75","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.devcel.2021.09.013","volume":"56","author":"L Jia","year":"2021","unstructured":"Jia L, Liao M, Mou A et al (2021) Rheb-regulated mitochondrial pyruvate metabolism of Schwann cells linked to axon stability. Dev Cell 56:2980-2994.e6. https:\/\/doi.org\/10.1016\/j.devcel.2021.09.013","journal-title":"Dev Cell"},{"key":"13928_CR76","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1074\/jbc.M115.699215","volume":"291","author":"MH Rahman","year":"2016","unstructured":"Rahman MH, Jha MK, Kim J-H et al (2016) Pyruvate dehydrogenase kinase-mediated glycolytic metabolic shift in the dorsal root ganglion drives painful diabetic neuropathy. J Biol Chem 291:6011\u20136025. https:\/\/doi.org\/10.1074\/jbc.M115.699215","journal-title":"J Biol Chem"},{"key":"13928_CR77","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nn.3809","volume":"17","author":"B Beirowski","year":"2014","unstructured":"Beirowski B, Babetto E, Golden JP et al (2014) Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance. Nat Neurosci 17:1351\u20131361. https:\/\/doi.org\/10.1038\/nn.3809","journal-title":"Nat Neurosci"},{"key":"13928_CR78","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1089\/ars.2021.0152","volume":"37","author":"E Eftekharpour","year":"2022","unstructured":"Eftekharpour E, Fernyhough P (2022) Oxidative stress and mitochondrial dysfunction associated with peripheral neuropathy in type 1 diabetes. Antioxid Redox Signal 37:578\u2013596. https:\/\/doi.org\/10.1089\/ars.2021.0152","journal-title":"Antioxid Redox Signal"},{"key":"13928_CR79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-015-0671-9","volume":"15","author":"P Fernyhough","year":"2015","unstructured":"Fernyhough P (2015) Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events. Curr Diab Rep 15:89. https:\/\/doi.org\/10.1007\/s11892-015-0671-9","journal-title":"Curr Diab Rep"},{"key":"13928_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2024.101972","volume":"79","author":"K Sriwastawa","year":"2024","unstructured":"Sriwastawa K, Kumar A (2024) Mitochondrial dysfunction in diabetic neuropathy: impaired mitophagy triggers NLRP3 inflammasome. Mitochondrion 79:101972. https:\/\/doi.org\/10.1016\/j.mito.2024.101972","journal-title":"Mitochondrion"},{"key":"13928_CR81","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1007\/s12035-020-01989-0","volume":"57","author":"AK Kalvala","year":"2020","unstructured":"Kalvala AK, Kumar R, Sherkhane B et al (2020) Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy. Mol Neurobiol 57:3616\u20133631. https:\/\/doi.org\/10.1007\/s12035-020-01989-0","journal-title":"Mol Neurobiol"},{"key":"13928_CR82","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1007\/s12035-023-03342-7","volume":"60","author":"Q Lin","year":"2023","unstructured":"Lin Q, Li K, Chen Y et al (2023) Oxidative stress in diabetic peripheral neuropathy: pathway and mechanism-based treatment. Mol Neurobiol 60:4574\u20134594. https:\/\/doi.org\/10.1007\/s12035-023-03342-7","journal-title":"Mol Neurobiol"},{"key":"13928_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109793","volume":"116","author":"I Khan","year":"2023","unstructured":"Khan I, Preeti K, Kumar R et al (2023) Piceatannol promotes neuroprotection by inducing mitophagy and mitobiogenesis in the experimental diabetic peripheral neuropathy and hyperglycemia-induced neurotoxicity. Int Immunopharmacol 116:109793. https:\/\/doi.org\/10.1016\/j.intimp.2023.109793","journal-title":"Int Immunopharmacol"},{"key":"13928_CR84","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/biof.1397","volume":"44","author":"P Bachewal","year":"2018","unstructured":"Bachewal P, Gundu C, Yerra VG et al (2018) Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. BioFactors 44:109\u2013122. https:\/\/doi.org\/10.1002\/biof.1397","journal-title":"BioFactors"},{"key":"13928_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09896-x","author":"J Xu","year":"2026","unstructured":"Xu J, Li Y, Novak C et al (2026) Mitochondrial transfer from glia to neurons protects against peripheral neuropathy. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09896-x","journal-title":"Nature"},{"key":"13928_CR86","doi-asserted-by":"publisher","DOI":"10.21037\/arh.2018.12.02","author":"OV Taso","year":"2019","unstructured":"Taso OV, Philippou A, Moustogiannis A et al (2019) Lipid peroxidation products and their role in neurodegenerative diseases. Ann Res Hosp. https:\/\/doi.org\/10.21037\/arh.2018.12.02","journal-title":"Ann Res Hosp"},{"key":"13928_CR87","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acn3.51639","volume":"9","author":"F Afshinnia","year":"2022","unstructured":"Afshinnia F, Reynolds EL, Rajendiran TM et al (2022) Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes. Ann Clin Transl Neurol 9:1392\u20131404. https:\/\/doi.org\/10.1002\/acn3.51639","journal-title":"Ann Clin Transl Neurol"},{"key":"13928_CR88","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/acn3.51367","volume":"8","author":"AE Rumora","year":"2021","unstructured":"Rumora AE, Guo K, Alakwaa FM et al (2021) Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes. Ann Clin Transl Neurol 8:1292\u20131307. https:\/\/doi.org\/10.1002\/acn3.51367","journal-title":"Ann Clin Transl Neurol"},{"key":"13928_CR89","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1210\/clinem\/dgab844","volume":"107","author":"K Guo","year":"2022","unstructured":"Guo K, Savelieff MG, Rumora AE et al (2022) Plasma metabolomics and lipidomics differentiate obese individuals by peripheral neuropathy status. J Clin Endocrinol Metab 107:1091\u20131109. https:\/\/doi.org\/10.1210\/clinem\/dgab844","journal-title":"J Clin Endocrinol Metab"},{"key":"13928_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107852","volume":"35","author":"V Fridman","year":"2021","unstructured":"Fridman V, Zarini S, Sillau S et al (2021) Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity. J Diabetes Complications 35:107852. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107852","journal-title":"J Diabetes Complications"},{"key":"13928_CR91","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/db06-1176","volume":"56","author":"IG Obrosova","year":"2007","unstructured":"Obrosova IG, Ilnytska O, Lyzogubov VV et al (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of \u201chealthy\u201d diet and aldose reductase inhibition. Diabetes 56:2598\u20132608. https:\/\/doi.org\/10.2337\/db06-1176","journal-title":"Diabetes"},{"key":"13928_CR92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SEM et al (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341\u2013350. https:\/\/doi.org\/10.1056\/NEJMoa032782","journal-title":"N Engl J Med"},{"key":"13928_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79276-0","author":"Z Cai","year":"2021","unstructured":"Cai Z, Yang Y, Zhang J (2021) A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-79276-0","journal-title":"Sci Rep"},{"key":"13928_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","volume":"14","author":"X Liu","year":"2019","unstructured":"Liu X, Xu Y, An M, Zeng Q (2019) The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS ONE 14:e0212574. https:\/\/doi.org\/10.1371\/journal.pone.0212574","journal-title":"PLoS ONE"},{"key":"13928_CR95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","volume":"1851","author":"S Schmitt","year":"2015","unstructured":"Schmitt S, Castelvetri LC, Simons M (2015) Metabolism and functions of lipids in myelin. Biochim Biophys Acta 1851:999\u20131005. https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.016","journal-title":"Biochim Biophys Acta"},{"key":"13928_CR96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MOL.0000000000000770","volume":"32","author":"Z Iqbal","year":"2021","unstructured":"Iqbal Z, Bashir B, Ferdousi M et al (2021) Lipids and peripheral neuropathy. Curr Opin Lipidol 32:249\u2013257. https:\/\/doi.org\/10.1097\/MOL.0000000000000770","journal-title":"Curr Opin Lipidol"},{"key":"13928_CR97","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.1523\/JNEUROSCI.3243-20.2021","volume":"41","author":"RM Follis","year":"2021","unstructured":"Follis RM, Tep C, Genaro-Mattos TC et al (2021) Metabolic control of sensory neuron survival by the p75 neurotrophin receptor in Schwann cells. J Neurosci 41:8710\u20138724. https:\/\/doi.org\/10.1523\/JNEUROSCI.3243-20.2021","journal-title":"J Neurosci"},{"key":"13928_CR98","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2014.09.001","volume":"9","author":"C Norrm\u00e9n","year":"2014","unstructured":"Norrm\u00e9n C, Figlia G, Lebrun-Julien F et al (2014) MTORC1 controls PNS myelination along the mTORC1-RXR\u03b3-SREBP-lipid biosynthesis axis in Schwann cells. Cell Rep 9:646\u2013660. https:\/\/doi.org\/10.1016\/j.celrep.2014.09.001","journal-title":"Cell Rep"},{"key":"13928_CR99","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1101\/gad.310490.117","volume":"32","author":"M Kim","year":"2018","unstructured":"Kim M, Wende H, Walcher J et al (2018) Maf links Neuregulin1 signaling to cholesterol synthesis in myelinating Schwann cells. Genes Dev 32:645\u2013657. https:\/\/doi.org\/10.1101\/gad.310490.117","journal-title":"Genes Dev"},{"key":"13928_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153389","volume":"11","author":"NCG Kwai","year":"2016","unstructured":"Kwai NCG, Nigole W, Poynten AM et al (2016) The relationship between dyslipidemia and acute axonal function in type 2 diabetes mellitus in vivo. PLoS ONE 11:e0153389. https:\/\/doi.org\/10.1371\/journal.pone.0153389","journal-title":"PLoS ONE"},{"key":"13928_CR101","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2337\/db08-1771","volume":"58","author":"TD Wiggin","year":"2009","unstructured":"Wiggin TD, Sullivan KA, Pop-Busui R et al (2009) Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58:1634\u20131640. https:\/\/doi.org\/10.2337\/db08-1771","journal-title":"Diabetes"},{"key":"13928_CR102","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/acn3.70072","volume":"12","author":"L Davalos","year":"2025","unstructured":"Davalos L, Callaghan BC, Muthukumar L et al (2025) The impact of diabetes and metabolic syndrome burden on pain, neuropathy severity and fiber type. Ann Clin Transl Neurol 12:1408\u20131417. https:\/\/doi.org\/10.1002\/acn3.70072","journal-title":"Ann Clin Transl Neurol"},{"key":"13928_CR103","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.042101","author":"PD O\u2019Brien","year":"2020","unstructured":"O\u2019Brien PD, Guo K, Eid SA et al (2020) Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.042101","journal-title":"Dis Model Mech"},{"key":"13928_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1194\/jlr.M086843","volume":"60","author":"AE Rumora","year":"2019","unstructured":"Rumora AE, LoGrasso G, Haidar JA et al (2019) Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons. J Lipid Res 60:58\u201370. https:\/\/doi.org\/10.1194\/jlr.M086843","journal-title":"J Lipid Res"},{"key":"13928_CR105","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1523\/JNEUROSCI.3173-18.2019","volume":"39","author":"AE Rumora","year":"2019","unstructured":"Rumora AE, LoGrasso G, Hayes JM et al (2019) The divergent roles of dietary saturated and monounsaturated fatty acids on nerve function in murine models of obesity. J Neurosci 39:3770\u20133781. https:\/\/doi.org\/10.1523\/JNEUROSCI.3173-18.2019","journal-title":"J Neurosci"},{"key":"13928_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2024.100542","author":"N Piccolo","year":"2025","unstructured":"Piccolo N, Wiggers A, Koubek EJ, Feldman EL (2025) Neuropathy and the metabolic syndrome. eNeurologicalSci. https:\/\/doi.org\/10.1016\/j.ensci.2024.100542","journal-title":"eNeurologicalSci"},{"key":"13928_CR107","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/ars.2013.5248","volume":"21","author":"LM Hinder","year":"2014","unstructured":"Hinder LM, Figueroa-Romero C, Pacut C et al (2014) Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. Antioxid Redox Signal 21:588\u2013600. https:\/\/doi.org\/10.1089\/ars.2013.5248","journal-title":"Antioxid Redox Signal"},{"key":"13928_CR108","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","volume":"34","author":"MY Pepino","year":"2014","unstructured":"Pepino MY, Kuda O, Samovski D, Abumrad NA (2014) Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu Rev Nutr 34:281\u2013303. https:\/\/doi.org\/10.1146\/annurev-nutr-071812-161220","journal-title":"Annu Rev Nutr"},{"key":"13928_CR109","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.diabres.2011.01.005","volume":"92","author":"L Bu","year":"2011","unstructured":"Bu L, Salto LM, De Leon KJ, De Leon M (2011) Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes. Diabetes Res Clin Pract 92:82\u201391. https:\/\/doi.org\/10.1016\/j.diabres.2011.01.005","journal-title":"Diabetes Res Clin Pract"},{"key":"13928_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1634262","author":"H Ohguro","year":"2025","unstructured":"Ohguro H, Higashide M, Nishikiori N et al (2025) The distinct effects of metformin and imeglimin on high glucose-induced alterations in metabolic function and reactive oxygen species production in mouse Schwann cells are modulated by pemafibrate and\/or fatty acid-binding proteins. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2025.1634262","journal-title":"Front Cell Neurosci"},{"key":"13928_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1398691","author":"Z Wang","year":"2025","unstructured":"Wang Z, Liu Z, Yang Q et al (2025) Causal relationships between plasma lipidome and diabetic neuropathy: a Mendelian randomization study. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1398691","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13928_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.921942","volume":"13","author":"AE Rumora","year":"2022","unstructured":"Rumora AE, Guo K, Hinder LM et al (2022) A high-fat diet disrupts nerve lipids and mitochondrial function in murine models of neuropathy. Front Physiol 13:921942. https:\/\/doi.org\/10.3389\/fphys.2022.921942","journal-title":"Front Physiol"},{"key":"13928_CR113","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1021\/acs.molpharmaceut.2c00707","volume":"20","author":"D Xiao","year":"2023","unstructured":"Xiao D, Chang W (2023) Phosphatidylserine in diabetes research. Mol Pharm 20:82\u201389. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00707","journal-title":"Mol Pharm"},{"key":"13928_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tcb.2017.08.011","volume":"28","author":"S Kameoka","year":"2018","unstructured":"Kameoka S, Adachi Y, Okamoto K et al (2018) Phosphatidic acid and cardiolipin coordinate mitochondrial dynamics. Trends Cell Biol 28:67\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2017.08.011","journal-title":"Trends Cell Biol"},{"key":"13928_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157656","volume":"150","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Li X, Gao Y et al (2026) Multi-level intervention of Tangluoning on mitochondrial thioredoxin deficiency in Schwann cells ameliorates diabetic peripheral neuropathy. Phytomedicine 150:157656. https:\/\/doi.org\/10.1016\/j.phymed.2025.157656","journal-title":"Phytomedicine"},{"key":"13928_CR116","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1194\/jlr.S092874","volume":"60","author":"JL Stith","year":"2019","unstructured":"Stith JL, Velazquez FN, Obeid LM (2019) Advances in determining signaling mechanisms of ceramide and role in disease. J Lipid Res 60:913\u2013918. https:\/\/doi.org\/10.1194\/jlr.S092874","journal-title":"J Lipid Res"},{"key":"13928_CR117","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00125-011-2384-1","volume":"55","author":"A Othman","year":"2012","unstructured":"Othman A, R\u00fctti MF, Ernst D et al (2012) Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia 55:421\u2013431. https:\/\/doi.org\/10.1007\/s00125-011-2384-1","journal-title":"Diabetologia"},{"key":"13928_CR118","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12017-016-8423-9","volume":"19","author":"SM Hammad","year":"2017","unstructured":"Hammad SM, Baker NL, El Abiad JM et al (2017) Increased plasma levels of select deoxy-ceramide and ceramide species are associated with increased odds of diabetic neuropathy in type 1 diabetes: a pilot study. Neuromol Med 19:46\u201356. https:\/\/doi.org\/10.1007\/s12017-016-8423-9","journal-title":"Neuromol Med"},{"key":"13928_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.635175","volume":"12","author":"K Roszczyc-Owsiejczuk","year":"2021","unstructured":"Roszczyc-Owsiejczuk K, Zabielski P (2021) Sphingolipids as a culprit of mitochondrial dysfunction in insulin resistance and type 2 diabetes. Front Endocrinol (Lausanne) 12:635175. https:\/\/doi.org\/10.3389\/fendo.2021.635175","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13928_CR120","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","volume":"177","author":"P Hammerschmidt","year":"2019","unstructured":"Hammerschmidt P, Ostkotte D, Nolte H et al (2019) CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity. Cell 177:1536-1552.e23. https:\/\/doi.org\/10.1016\/j.cell.2019.05.008","journal-title":"Cell"},{"key":"13928_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030581","author":"LB Fugio","year":"2020","unstructured":"Fugio LB, Coeli-Lacchini FB, Leopoldino AM (2020) Sphingolipids and mitochondrial dynamic. Cells. https:\/\/doi.org\/10.3390\/cells9030581","journal-title":"Cells"},{"key":"13928_CR122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10863-016-9646-z","volume":"49","author":"M Colombini","year":"2017","unstructured":"Colombini M (2017) Ceramide channels and mitochondrial outer membrane permeability. J Bioenerg Biomembr 49:57\u201364. https:\/\/doi.org\/10.1007\/s10863-016-9646-z","journal-title":"J Bioenerg Biomembr"},{"key":"13928_CR123","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1096\/fj.201801417R","volume":"33","author":"HA Kalpage","year":"2019","unstructured":"Kalpage HA, Bazylianska V, Recanati MA et al (2019) Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis. FASEB J 33:1540\u20131553. https:\/\/doi.org\/10.1096\/fj.201801417R","journal-title":"FASEB J"},{"key":"13928_CR124","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur S, Wang ST, Chan PW et al (2014) CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 20:687\u2013695. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.015","journal-title":"Cell Metab"},{"key":"13928_CR125","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1096\/fj.201700300R","volume":"32","author":"BA Law","year":"2018","unstructured":"Law BA, Liao X, Moore KS et al (2018) Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes. FASEB J 32:1403\u20131416. https:\/\/doi.org\/10.1096\/fj.201700300R","journal-title":"FASEB J"},{"key":"13928_CR126","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/346783","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2015","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Hof PR, \u0160imi\u0107 G (2015) Ceramides in Alzheimer\u2019s disease: key mediators of neuronal apoptosis induced by oxidative stress and A\u03b2 accumulation. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2015\/346783","journal-title":"Oxid Med Cell Longev"},{"key":"13928_CR127","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1074\/jbc.M112.402719","volume":"288","author":"H Zigdon","year":"2013","unstructured":"Zigdon H, Kogot-Levin A, Park J-W et al (2013) Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J Biol Chem 288:4947\u20134956. https:\/\/doi.org\/10.1074\/jbc.M112.402719","journal-title":"J Biol Chem"},{"key":"13928_CR128","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2021.02.016","volume":"167","author":"M Bekhite","year":"2021","unstructured":"Bekhite M, Gonz\u00e1lez-Delgado A, H\u00fcbner S et al (2021) The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy. Free Radic Biol Med 167:66\u201380. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.02.016","journal-title":"Free Radic Biol Med"},{"key":"13928_CR129","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i6.105592","volume":"16","author":"W-S Xu","year":"2025","unstructured":"Xu W-S, Xing H, Wang Q-Q et al (2025) Identification and validation of serum amino acids as diagnostic biomarkers for diabetic peripheral neuropathy. World J Diabetes 16:105592. https:\/\/doi.org\/10.4239\/wjd.v16.i6.105592","journal-title":"World J Diabetes"},{"key":"13928_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2836","author":"T Ganz","year":"2017","unstructured":"Ganz T, Wainstein J, Gilad S et al (2017) Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. Diabetes Metab Res Rev. https:\/\/doi.org\/10.1002\/dmrr.2836","journal-title":"Diabetes Metab Res Rev"},{"key":"13928_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-017-1508-x","author":"LJ Rond\u00f3n","year":"2018","unstructured":"Rond\u00f3n LJ, Farges MC, Davin N, Sion B, Privat AM, Vasson MP, Eschalier A, Courteix C (2018) L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration. Euro J Nutr. https:\/\/doi.org\/10.1007\/s00394-017-1508-x","journal-title":"Euro J Nutr"},{"key":"13928_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21394-y","author":"M Doty","year":"2022","unstructured":"Doty M, Yun S, Wang Y et al (2022) Integrative multiomic analyses of dorsal root ganglia in diabetic neuropathic pain using proteomics, phospho-proteomics, and metabolomics. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-21394-y","journal-title":"Sci Rep"},{"key":"13928_CR133","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd5046","volume":"7","author":"H Sato","year":"2021","unstructured":"Sato H, Takado Y, Toyoda S et al (2021) Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model. Sci Adv 7:eabd5046. https:\/\/doi.org\/10.1126\/sciadv.abd5046","journal-title":"Sci Adv"},{"key":"13928_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108668","volume":"259","author":"A Bagues","year":"2024","unstructured":"Bagues A, Hu J, Alshanqiti I, Chung M-K (2024) Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain. Pharmacol Ther 259:108668. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108668","journal-title":"Pharmacol Ther"},{"key":"13928_CR135","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aav0558","volume":"363","author":"PJ White","year":"2019","unstructured":"White PJ, Newgard CB (2019) Branched-chain amino acids and cardiometabolic diseases: biomarker, causal agent, or both? Science (New York, NY) 363:582. https:\/\/doi.org\/10.1126\/science.aav0558","journal-title":"Science (New York, NY)"},{"key":"13928_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402086","author":"Z-Y Zhou","year":"2024","unstructured":"Zhou Z-Y, Wang J-Y, Li Z-X, Zhou Z-Y, Wang J-Y, Li Z-X et al (2024) Branched\u2010chain amino acids deficiency promotes diabetic neuropathic pain through upregulating LAT1 and inhibiting Kv1.2 channel. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202402086","journal-title":"Adv Sci"},{"key":"13928_CR137","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/1673-5374.177745","volume":"11","author":"Q-R Li","year":"2016","unstructured":"Li Q-R, Wang Z, Zhou W et al (2016) Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Neural Regen Res 11:345\u2013351. https:\/\/doi.org\/10.4103\/1673-5374.177745","journal-title":"Neural Regen Res"},{"key":"13928_CR138","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1212\/01.wnl.0000216260.39452.bf","volume":"66","author":"S Misawa","year":"2006","unstructured":"Misawa S, Kuwabara S, Kanai K et al (2006) Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics. Neurology 66:1545\u20131549. https:\/\/doi.org\/10.1212\/01.wnl.0000216260.39452.bf","journal-title":"Neurology"},{"key":"13928_CR139","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12964-025-02326-5","volume":"23","author":"TW Kim","year":"2025","unstructured":"Kim TW, Oum S-J, Lim JH et al (2025) Strengthening monocarboxylate transporters by adiponectin receptor agonist ameliorates diabetic peripheral neuropathy. Cell Commun Signal 23:342. https:\/\/doi.org\/10.1186\/s12964-025-02326-5","journal-title":"Cell Commun Signal"},{"key":"13928_CR140","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1210\/en.2008-0869","volume":"149","author":"TD Wiggin","year":"2008","unstructured":"Wiggin TD, Kretzler M, Pennathur S et al (2008) Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA\/2J mice. Endocrinology 149:4928\u20134937. https:\/\/doi.org\/10.1210\/en.2008-0869","journal-title":"Endocrinology"},{"key":"13928_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117557","author":"SE Elkholy","year":"2020","unstructured":"Elkholy SE, Elaidy SM, El-Sherbeeny NA et al (2020) Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: targeting Nav1.7 channels and PPAR-\u03b3. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.117557","journal-title":"Life Sci"},{"key":"13928_CR142","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2337\/db14-1325","volume":"64","author":"A Othman","year":"2015","unstructured":"Othman A, Bianchi R, Alecu I et al (2015) Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats. Diabetes 64:1035\u20131045. https:\/\/doi.org\/10.2337\/db14-1325","journal-title":"Diabetes"},{"key":"13928_CR143","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jacl.2015.03.011","volume":"9","author":"A Othman","year":"2015","unstructured":"Othman A, Benghozi R, Alecu I et al (2015) Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: a novel approach for treating diabetic neuropathy? J Clin Lipidol 9:568\u2013575. https:\/\/doi.org\/10.1016\/j.jacl.2015.03.011","journal-title":"J Clin Lipidol"},{"key":"13928_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083204","volume":"9","author":"YR Cho","year":"2014","unstructured":"Cho YR, Lim JH, Kim MY et al (2014) Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db\/db mice. PLoS ONE 9:e83204. https:\/\/doi.org\/10.1371\/journal.pone.0083204","journal-title":"PLoS ONE"},{"key":"13928_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315442","author":"A Balram","year":"2022","unstructured":"Balram A, Thapa S, Chatterjee S (2022) Glycosphingolipids in diabetes, oxidative stress, and cardiovascular disease: prevention in experimental animal models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315442","journal-title":"Int J Mol Sci"},{"key":"13928_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00408-1","author":"K Belarbi","year":"2020","unstructured":"Belarbi K, Cuvelier E, Bonte M-A et al (2020) Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-020-00408-1","journal-title":"Mol Neurodegener"},{"key":"13928_CR147","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2147\/DMSO.S65500","volume":"7","author":"J Hern\u00e1ndez-Ojeda","year":"2014","unstructured":"Hern\u00e1ndez-Ojeda J, Rom\u00e1n-Pintos LM, Rodr\u00edguez-Carr\u00edzalez AD et al (2014) Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study. Diabetes Metab Syndr Obes 7:401\u2013407. https:\/\/doi.org\/10.2147\/DMSO.S65500","journal-title":"Diabetes Metab Syndr Obes"},{"key":"13928_CR148","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/756294","author":"G Villegas-Rivera","year":"2015","unstructured":"Villegas-Rivera G, Rom\u00e1n-Pintos LM, Cardona-Mu\u00f1oz EG et al (2015) Effects of ezetimibe\/simvastatin and rosuvastatin on oxidative stress in diabetic neuropathy: a randomized, double-blind, placebo-controlled clinical trial. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2015\/756294","journal-title":"Oxid Med Cell Longev"},{"key":"13928_CR149","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2337\/dc20-1004","volume":"43","author":"FP Kristensen","year":"2020","unstructured":"Kristensen FP, Christensen DH, Callaghan BC et al (2020) Statin therapy and risk of polyneuropathy in type 2 diabetes: a Danish cohort study. Diabetes Care 43:2945\u20132952. https:\/\/doi.org\/10.2337\/dc20-1004","journal-title":"Diabetes Care"},{"key":"13928_CR150","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/mus.27447","volume":"65","author":"T Wannarong","year":"2022","unstructured":"Wannarong T, Chaikijurajai T, Preston DC et al (2022) Statins and the risk of polyneuropathy: a systematic review and two meta-analyses. Muscle Nerve 65:120\u2013125. https:\/\/doi.org\/10.1002\/mus.27447","journal-title":"Muscle Nerve"},{"key":"13928_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15030367","author":"F Sztanek","year":"2026","unstructured":"Sztanek F, T\u00f3th LI, Herny\u00e1k M et al (2026) Targeting oxidative stress and mitochondrial dysfunction in diabetic neuropathy: mechanisms and therapeutic opportunities. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox15030367","journal-title":"Antioxidants (Basel)"},{"key":"13928_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1268619","author":"C Liu","year":"2023","unstructured":"Liu C, Wu T, Ren N (2023) Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2023.1268619","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13928_CR153","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1463-1326.2011.01431.x","volume":"13","author":"CG Jolivalt","year":"2011","unstructured":"Jolivalt CG, Fineman M, Deacon CF et al (2011) GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes Obes Metab 13:990\u20131000. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01431.x","journal-title":"Diabetes Obes Metab"},{"key":"13928_CR154","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/bcp.14063","volume":"85","author":"C Brock","year":"2019","unstructured":"Brock C, Hansen CS, Karmisholt J et al (2019) Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy. Br J Clin Pharmacol 85:2512\u20132523. https:\/\/doi.org\/10.1111\/bcp.14063","journal-title":"Br J Clin Pharmacol"},{"key":"13928_CR155","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jdiacomp.2015.07.013","volume":"29","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Martin CL, Brown MB et al (2015) Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open label randomized study. J Diabetes Complications 29:1287\u20131294. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.07.013","journal-title":"J Diabetes Complications"},{"key":"13928_CR156","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001420","volume":"8","author":"G Ponirakis","year":"2020","unstructured":"Ponirakis G, Abdul-Ghani MA, Jayyousi A et al (2020) Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study. BMJ Open Diabetes Res Care 8:e001420. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001420","journal-title":"BMJ Open Diabetes Res Care"},{"key":"13928_CR157","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/2050640620925968","volume":"8","author":"A-ML Wegeberg","year":"2020","unstructured":"Wegeberg A-ML, Hansen CS, Farmer AD et al (2020) Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: a randomised, double-blind, placebo-controlled trial. United European Gastroenterol J 8:695\u2013704. https:\/\/doi.org\/10.1177\/2050640620925968","journal-title":"United European Gastroenterol J"},{"key":"13928_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16242","volume":"169","author":"S Fan","year":"2025","unstructured":"Fan S, Qiu Y, Liu J et al (2025) Effect of the glucagon-like peptide-1 receptor agonists on diabetic peripheral neuropathy: a meta-analysis. J Neurochem 169:e16242. https:\/\/doi.org\/10.1111\/jnc.16242","journal-title":"J Neurochem"},{"key":"13928_CR159","doi-asserted-by":"publisher","DOI":"10.1111\/jns.70011","volume":"30","author":"U Adhikari","year":"2025","unstructured":"Adhikari U, Gad H, Chatterjee D et al (2025) Dapagliflozin for small nerve fibre regeneration in diabetic peripheral neuropathy: a randomised controlled Study (DINE). J Peripher Nerv Syst 30:e70011. https:\/\/doi.org\/10.1111\/jns.70011","journal-title":"J Peripher Nerv Syst"},{"key":"13928_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70128","volume":"8","author":"M Vafaeinasab","year":"2025","unstructured":"Vafaeinasab M, Mirzaei Malekabad F, Khatibi A et al (2025) The comparison of the effect of adding empagliflozin to the medication regimen on peripheral neuropathy in patients with type II diabetes: a double blind randomised clinical trial. Endocrinol Diabetes Metab 8:e70128. https:\/\/doi.org\/10.1002\/edm2.70128","journal-title":"Endocrinol Diabetes Metab"},{"key":"13928_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.926717","author":"M Kandeel","year":"2022","unstructured":"Kandeel M (2022) The outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2I) on diabetes-associated neuropathy: a systematic review and meta-analysis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.926717","journal-title":"Front Pharmacol"},{"key":"13928_CR162","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/ANNALS-25-01262","volume":"179","author":"FPB Kristensen","year":"2026","unstructured":"Kristensen FPB, Christensen DH, Callaghan BC et al (2026) Effectiveness of Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists on diabetic foot disease\u202f: an emulated target trial. Ann Intern Med 179:340\u2013352. https:\/\/doi.org\/10.7326\/ANNALS-25-01262","journal-title":"Ann Intern Med"},{"key":"13928_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101331","volume":"48","author":"J Liao","year":"2022","unstructured":"Liao J, Kang A, Xia C et al (2022) The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial. Diabetes Metab 48:101331. https:\/\/doi.org\/10.1016\/j.diabet.2022.101331","journal-title":"Diabetes Metab"},{"key":"13928_CR164","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1534734619878090","volume":"19","author":"E Papadokostaki","year":"2020","unstructured":"Papadokostaki E, Rizos E, Tigas S, Liberopoulos EN (2020) Canagliflozin and amputation risk: evidence so far. Int J Low Extrem Wounds 19:21\u201326. https:\/\/doi.org\/10.1177\/1534734619878090","journal-title":"Int J Low Extrem Wounds"},{"key":"13928_CR165","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10072-020-04681-2","volume":"42","author":"A Syngle","year":"2021","unstructured":"Syngle A, Chahal S, Vohra K (2021) Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurol Sci 42:1429\u20131436. https:\/\/doi.org\/10.1007\/s10072-020-04681-2","journal-title":"Neurol Sci"},{"key":"13928_CR166","doi-asserted-by":"publisher","DOI":"10.1590\/0004-2730000002914","author":"JIT Barros","year":"2014","unstructured":"Barros JIT, Fechine FV, Montenegro J\u00fanior RM et al (2014) Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metab. https:\/\/doi.org\/10.1590\/0004-2730000002914","journal-title":"Arq Bras Endocrinol Metab"},{"key":"13928_CR167","doi-asserted-by":"crossref","unstructured":"Liu J, Li W, Li C, et al (2025) Pyruvate kinase activates SARM1 to exacerbate axonal degeneration in diabetic peripheral neuropathy. 2025.05.28.656718","DOI":"10.1101\/2025.05.28.656718"},{"key":"13928_CR168","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1007\/s12035-025-04835-3","volume":"62","author":"A Karnik","year":"2025","unstructured":"Karnik A, Joshi A (2025) SARM1: The checkpoint of axonal degeneration in the nervous system disorders. Mol Neurobiol 62:9240\u20139257. https:\/\/doi.org\/10.1007\/s12035-025-04835-3","journal-title":"Mol Neurobiol"},{"key":"13928_CR169","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/antiox14070808","volume":"14","author":"H Murata","year":"2025","unstructured":"Murata H, Ogawa K, Yasui Y et al (2025) Carnosol, a Rosemary ingredient discovered in a screen for inhibitors of SARM1-NAD+ cleavage activity, ameliorates symptoms of peripheral neuropathy. Antioxidants (Basel) 14:808. https:\/\/doi.org\/10.3390\/antiox14070808","journal-title":"Antioxidants (Basel)"},{"key":"13928_CR170","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1038\/s41467-024-50354-5","volume":"15","author":"JR Tribble","year":"2024","unstructured":"Tribble JR, J\u00f6e M, Varricchio C et al (2024) NMNAT2 is a druggable target to drive neuronal NAD production. Nat Commun 15:6256. https:\/\/doi.org\/10.1038\/s41467-024-50354-5","journal-title":"Nat Commun"},{"key":"13928_CR171","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-023-00690-9","volume":"19","author":"S Yang","year":"2024","unstructured":"Yang S, Niou Z-X, Enriquez A et al (2024) NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Mol Neurodegener 19:13. https:\/\/doi.org\/10.1186\/s13024-023-00690-9","journal-title":"Mol Neurodegener"},{"key":"13928_CR172","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui R, Boulton AJM, Feldman EL et al (2017) Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40:136\u2013154. https:\/\/doi.org\/10.2337\/dc16-2042","journal-title":"Diabetes Care"},{"key":"13928_CR173","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40279-021-01596-6","volume":"52","author":"F Streckmann","year":"2022","unstructured":"Streckmann F, Balke M, Cavaletti G et al (2022) Exercise and neuropathy: systematic review with meta-analysis. Sports Med 52:1043\u20131065. https:\/\/doi.org\/10.1007\/s40279-021-01596-6","journal-title":"Sports Med"},{"key":"13928_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.756940","volume":"8","author":"Y-H Zhang","year":"2021","unstructured":"Zhang Y-H, Hu H-Y, Xiong Y-C et al (2021) Exercise for neuropathic pain: a systematic review and expert consensus. Front Med (Lausanne) 8:756940. https:\/\/doi.org\/10.3389\/fmed.2021.756940","journal-title":"Front Med (Lausanne)"},{"key":"13928_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109183","volume":"183","author":"G Orlando","year":"2022","unstructured":"Orlando G, Balducci S, Boulton AJM et al (2022) Neuromuscular dysfunction and exercise training in people with diabetic peripheral neuropathy: a narrative review. Diabetes Res Clin Pract 183:109183. https:\/\/doi.org\/10.1016\/j.diabres.2021.109183","journal-title":"Diabetes Res Clin Pract"},{"key":"13928_CR176","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1249\/MSS.0000000000002800","volume":"54","author":"JA Kanaley","year":"2022","unstructured":"Kanaley JA, Colberg SR, Corcoran MH et al (2022) Exercise\/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Med Sci Sports Exerc 54:353\u2013368. https:\/\/doi.org\/10.1249\/MSS.0000000000002800","journal-title":"Med Sci Sports Exerc"},{"key":"13928_CR177","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/biomedicines13071607","volume":"13","author":"E Davidson","year":"2025","unstructured":"Davidson E, Obrosov O, Coppey L, Yorek M (2025) Omega-3 polyunsaturated fatty acids (PUFAs) and diabetic peripheral neuropathy: a pre-clinical study examining the effect of Omega-3 PUFAs from fish oil, krill oil, algae or pharmaceutical-derived ethyl esters using type 2 diabetic rats. Biomedicines 13:1607. https:\/\/doi.org\/10.3390\/biomedicines13071607","journal-title":"Biomedicines"},{"key":"13928_CR178","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1212\/WNL.0000000000004033","volume":"88","author":"EJH Lewis","year":"2017","unstructured":"Lewis EJH, Perkins BA, Lovblom LE et al (2017) Effect of omega-3 supplementation on neuropathy in type 1 diabetes: a 12-month pilot trial. Neurology 88:2294\u20132301. https:\/\/doi.org\/10.1212\/WNL.0000000000004033","journal-title":"Neurology"},{"key":"13928_CR179","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014623.pub2","author":"AC Britten-Jones","year":"2025","unstructured":"Britten-Jones AC, Linstrom TA, Makrai E et al (2025) Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD014623.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"13928_CR180","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/j.pain.0000000000002401","volume":"163","author":"J Enders","year":"2022","unstructured":"Enders J, Swanson MT, Ryals J, Wright DE (2022) A ketogenic diet reduces mechanical allodynia and improves epidermal innervation in diabetic mice. Pain 163:682\u2013689. https:\/\/doi.org\/10.1097\/j.pain.0000000000002401","journal-title":"Pain"},{"key":"13928_CR181","doi-asserted-by":"publisher","first-page":"e1207","DOI":"10.1097\/j.pain.0000000000002667","volume":"163","author":"JD Enders","year":"2022","unstructured":"Enders JD, Thomas S, Swanson MT et al (2022) Ketogenic diet prevents methylglyoxal-evoked nociception by scavenging methylglyoxal. Pain 163:e1207\u2013e1216. https:\/\/doi.org\/10.1097\/j.pain.0000000000002667","journal-title":"Pain"},{"key":"13928_CR182","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2337\/db23-0006","volume":"73","author":"R Jin","year":"2024","unstructured":"Jin R, Wang J, Li M et al (2024) Discovery of a novel benzothiadiazine-based selective aldose reductase inhibitor as potential therapy for diabetic peripheral neuropathy. Diabetes 73:497\u2013510. https:\/\/doi.org\/10.2337\/db23-0006","journal-title":"Diabetes"},{"key":"13928_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105863","volume":"180","author":"F Aizawa","year":"2024","unstructured":"Aizawa F, Kajimoto H, Okabayashi A et al (2024) Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferase. Neurochem Int 180:105863. https:\/\/doi.org\/10.1016\/j.neuint.2024.105863","journal-title":"Neurochem Int"},{"key":"13928_CR184","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1159\/000494174","volume":"50","author":"Y Lu","year":"2018","unstructured":"Lu Y, Yao J, Gong C et al (2018) Gentiopicroside ameliorates diabetic peripheral neuropathy by modulating PPAR- \u0393\/AMPK\/ACC signaling pathway. Cell Physiol Biochem 50:585\u2013596. https:\/\/doi.org\/10.1159\/000494174","journal-title":"Cell Physiol Biochem"},{"key":"13928_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154434","volume":"107","author":"J Yang","year":"2022","unstructured":"Yang J, Wei Y, Zhao T et al (2022) Magnolol effectively ameliorates diabetic peripheral neuropathy in mice. Phytomedicine 107:154434. https:\/\/doi.org\/10.1016\/j.phymed.2022.154434","journal-title":"Phytomedicine"},{"key":"13928_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105985","volume":"175","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Zhang X, Wei W et al (2022) Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res 175:105985. https:\/\/doi.org\/10.1016\/j.phrs.2021.105985","journal-title":"Pharmacol Res"},{"key":"13928_CR187","first-page":"1561","volume":"35","author":"L Yu","year":"2019","unstructured":"Yu L, Zhao Z (2019) Effect of lalulopeptide on nerve conduction velocity, platelet lymphocyte ratio and plasma HCY level in patients with type 2 diabetic peripheral neuropathy. Acta Med Mediterr 35:1561\u20131565","journal-title":"Acta Med Mediterr"},{"key":"13928_CR188","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.clinph.2021.05.033","volume":"132","author":"T Issar","year":"2021","unstructured":"Issar T, Kwai NCG, Poynten AM et al (2021) Effect of exenatide on peripheral nerve excitability in type 2 diabetes. Clin Neurophysiol 132:2532\u20132539. https:\/\/doi.org\/10.1016\/j.clinph.2021.05.033","journal-title":"Clin Neurophysiol"},{"key":"13928_CR189","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2337\/db23-0997","volume":"73","author":"SA Eid","year":"2024","unstructured":"Eid SA, Elzinga SE, Kim B et al (2024) High-intensity interval training, caloric restriction, or their combination have beneficial effects on metabolically acquired peripheral neuropathy. Diabetes 73:1895\u20131907. https:\/\/doi.org\/10.2337\/db23-0997","journal-title":"Diabetes"},{"key":"13928_CR190","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5020465","author":"L Coppey","year":"2019","unstructured":"Coppey L, Davidson E, Shevalye H et al (2019) Effect of early and late interventions with dietary oils on vascular and neural complications in a type 2 diabetic rat model. J Diabetes Res. https:\/\/doi.org\/10.1155\/2019\/5020465","journal-title":"J Diabetes Res"},{"key":"13928_CR191","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1152\/jn.00224.2015","volume":"114","author":"H Shevalye","year":"2015","unstructured":"Shevalye H, Yorek MS, Coppey LJ et al (2015) Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J Neurophysiol 114:199\u2013208. https:\/\/doi.org\/10.1152\/jn.00224.2015","journal-title":"J Neurophysiol"},{"key":"13928_CR192","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2967127","author":"EP Davidson","year":"2018","unstructured":"Davidson EP, Coppey LJ, Shevalye H et al (2018) Effect of dietary content of menhaden oil with or without salsalate on neuropathic endpoints in high-fat-fed\/low-dose streptozotocin-treated Sprague Dawley rats. J Diabetes Res. https:\/\/doi.org\/10.1155\/2018\/2967127","journal-title":"J Diabetes Res"},{"key":"13928_CR193","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300354R","volume":"37","author":"SA Eid","year":"2023","unstructured":"Eid SA, O\u2019Brien PD, Kretzler KH et al (2023) Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db\/db mouse model of type 2 diabetes. FASEB J 37:e23115. https:\/\/doi.org\/10.1096\/fj.202300354R","journal-title":"FASEB J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13928-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13928-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13928-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:21:31Z","timestamp":1783495291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13928-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":193,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13928"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13928-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"419"}}